Health Health

Friday

When Dr. Tiffany M. Osborn received her COVID-19 vaccination shortly after vaccines became available in late 2020, she felt hopeful about the pandemic's trajectory. A year later, she's sad and frustrated to see so many COVID patients in the ICU. Matt Miller / Washington University School of Medicine hide caption

toggle caption
Matt Miller / Washington University School of Medicine

ICU teams report fatigue and frustration as they brace for omicron surge

  • Download
  • <iframe src="https://www.npr.org/player/embed/1069497328/1069539036" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An public safety message from the government of South Africa. The country announced on Thursday that it was past the peak of its latest coronavirus surge. South African Government/Twitter hide caption

toggle caption
South African Government/Twitter

Trucks drive in front of Teva Pharmaceutical Logistic Center in the town of Shoam, Israel, on Oct. 16, 2013. On Thursday, a jury held Teva responsible for contributing to the opioid crisis. Dan Balilty/AP hide caption

toggle caption
Dan Balilty/AP

Car keys are shown by glasses with alcohol in this stock photo illustration. Companies are developing technology that would allow cars to stop people from driving when drunk. Peter Dazeley/Getty Images hide caption

toggle caption
Peter Dazeley/Getty Images

What if cars could stop you from driving drunk? A peek at the latest tech

  • Download
  • <iframe src="https://www.npr.org/player/embed/1065246981/1068587905" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Victoria Gray, who has sickle cell disease, volunteered for one of the most anticipated medical experiments in decades: the first attempt to use the gene-editing technique CRISPR to treat a genetic disorder in the United States. Meredith Rizzo/NPR hide caption

toggle caption
Meredith Rizzo/NPR

First sickle cell patient treated with CRISPR gene-editing still thriving

  • Download
  • <iframe src="https://www.npr.org/player/embed/1067400512/1069434903" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Thomas Hansmann/Pfizer

The COVID antiviral drugs are here but they're scarce. Here's what to know

  • Download
  • <iframe src="https://www.npr.org/player/embed/1069323181/1069739439" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Health care workers administer COVID-19 tests at a drive-through clinic in Sydney, Friday, Dec. 31. Australian health authorities have reported a record 32,000 new virus cases, many of them in Sydney. Bianca De Marchi/AP hide caption

toggle caption
Bianca De Marchi/AP

Thursday

The Carnival Cruise Line's Carnival Sunrise ship is seen in the port of Miami on Dec. 23, 2020, amid the coronavirus pandemic. Daniel Slim/AFP via Getty Images hide caption

toggle caption
Daniel Slim/AFP via Getty Images

The top Fresh Air web stories of 2021 reflect the show's status as a place where artists, authors and journalists speak to the moment. Valerie Macon/AFP; Grace Cary; Chip Somodevilla/Getty Images hide caption

toggle caption
Valerie Macon/AFP; Grace Cary; Chip Somodevilla/Getty Images

Activists participate in a candlelight vigil calling for an end to the nation's opioid addiction crisis at the Ellipse in Washington, D.C., in August 2017. Alex Wong/Getty Images hide caption

toggle caption
Alex Wong/Getty Images

More than a million Americans have died from overdoses during the opioid epidemic

  • Download
  • <iframe src="https://www.npr.org/player/embed/1069062738/1069276285" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

A health care worker holds doses of J&J vaccines at the Gandhi Phoenix Settlement in Bhambayi township, South Africa, on Sept. 24. A study of the J&J booster shot in the country had promising results against the omicron variant. Rajesh Jantilal/AFP via Getty Images hide caption

toggle caption
Rajesh Jantilal/AFP via Getty Images

New COVID studies show promise for the Johnson & Johnson vaccine booster

  • Download
  • <iframe src="https://www.npr.org/player/embed/1069053093/1069276994" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript